NCL  
Nanotechnology Characterization Laboratory Skip Navigation
 

NCL Nanoparticles

The following list annotates nanoparticles characterized at the Nanotechnology Characterization Laboratory. Inclusion does not necessarily indicate that the nanoparticle will be tested in each assay of the characterization cascade.


  NCL ID Class Description
NCL1 dendrimer G4 PAMAM DAB core, PEG surface, commercial source
NCL2 dendrimer G5 PAMAM DAB core, PEG surface, commercial source
NCL3 dendrimer G6 PAMAM DAB core, PEG surface, commercial source
NCL4 dendrimer G6 PAMAM DAB core, Amine surface, commercial source
NCL5 dendrimer G6 PAMAM DAB core, Succinamic acid surface, commercial source
NCL6 dendrimer G6 PAMAM DAB core, Amidoethanol surface, commercial source
NCL7 polymer 20 nm polystyrene microspheres, commercial source
NCL8 polymer 50 nm polystyrene microspheres, commercial source
NCL9 polymer 80 nm polystyrene microspheres, commercial source
NCL10 metal colloid 5 nm Gold colloid, commercial source
NCL11 metal colloid 10 nm Gold colloid, commercial source
NCL12 metal colloid 20 nm Gold colloid, commercial source
NCL13 metal colloid 30 nm Gold colloid, commercial source
NCL14 metal colloid 40 nm Gold colloid, commercial source
NCL15 metal colloid 50 nm Gold colloid, commercial source
NCL16 fullerene Proprietary formulation
NCL17 fullerene Proprietary formulation
NCL18 fullerene Proprietary formulation
NCL19 fullerene Proprietary formulation
NCL20 dendrimer Proprietary formulation
NCL21 dendrimer Proprietary formulation
NCL22 dendrimer Proprietary formulation
NCL23 dendrimer Proprietary formulation
NCL24 Magnevist Commercial formulation
NCL25 dendrimer Proprietary formulation
NCL26 dendrimer Proprietary formulation
NCL27 dendrimer Proprietary formulation
NCL28 dendrimer Proprietary formulation
NCL29 dendrimer Proprietary formulation
NCL30 dendrimer Proprietary formulation
NCL31 dendrimer Proprietary formulation
NCL32 dendrimer Proprietary formulation
NCL33 dendrimer Proprietary formulation
NCL34 dendrimer Proprietary formulation
NCL35 dendrimer Proprietary formulation
NCL36 dendrimer Proprietary formulation
NCL37 dendrimer Proprietary formulation
NCL38 dendrimer Proprietary formulation
NCL39 dendrimer Proprietary formulation
NCL40 dendrimer Proprietary formulation
NCL41 dendrimer Proprietary formulation
 
       
       
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.govNCI - Alliance for Nanotechnology in Cancer
National Cancer Institute U.S. National Institutes of Health www.cancer.gov Nanotechnology Characterization Lab